Alembic Pharma appoints Prag Goel as Vice President - Sales and Marketing (Megacare, Enteron and Osteofit business divisions)
Vadodara: Alembic Pharma has announced the appointment of Prag Goel as Vice President - Sales and Marketing (Megacare, Enteron and Osteofit business divisions) of the Company w.e.f. 1st January, 2025.
Prag Goel has completed his B.Sc. from Kurukshetra University. Goel is an experienced professional in the pharmaceutical industry with about 30 years of progressive experience and has worked in teams across various therapy areas such as Pediatrics, Cardiovascular, Diabetic, Anti Infective, Gastrointestinal, Gynecology, Rheumatology, Anti T.B, dermatology, Anti Infective and critical care in Indian as well as multi-national organizations. He has expertise in consistently developing high performance sales team and meeting business objectives. He was associated with LupinLimited, Glenmark India Limited, Pfizer India Limited and AstraZeneca Pharma India Ltd, and other various esteemed organizations.
Read also: Glenmark's Win: NPPA revises price of Telmisartan, Cilnidipine FDC after data review
Medical Dialogues team had earlier reported that the Company had received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Divalproex Sodium Delayed-Release Capsules USP, 125 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Depakote Sprinkle Capsules, 125 mg, of AbbVie Inc.
Read also: Alembic Pharma bags USFDA nod for anti-epileptic drug
Alembic Pharmaceuticals is engaged in the development, manufacturing, and marketing of a wide range of pharmaceutical products. Founded in 1907 and headquartered in Vadodara, Gujarat, Alembic specializes in generic drugs, active pharmaceutical ingredients (APIs), and over-the-counter (OTC) products. The company has a global presence, with operations in over 75 countries, including the U.S., Europe, and emerging markets. Alembic is known for its medicines across therapeutic segments such as cardiovascular, anti-infective, pain management, and oncology.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.